The FDA announced on June 16, 2026, that Medtronic MiniMed is recalling the MiniMed Go App (models MMT-8600 and MMT-8601) because nighttime alerts for missed doses or high glucose may fail to trigger. This defect could result in users missing rapid-acting insulin doses without knowing it.
How to tell if you have it
- Brand: Medtronic MiniMed
- Product: MiniMed Go App
- Model: MMT-8600 (iOS), MMT-8601 (Android)
- Software Versions: 1.0.0, 1.1.0
- Model/UDI-DI: MMT-8600/00199150038978(10)1.1.0, MMT-8601/00199150038985(10)1.1.0
- Distribution: US Nationwide (including PR, OH, WA, IL, NC, PA, VA, MN, ID, CA, UT, MI, NJ, MS, SC, CO, AZ, OR, AR, MO, TX, AL, FL, NY, IN, TN, IA, WI, MA, LA, OK, GA, KS, NM, CT, KY, NH, NV, MD) and Australia, Switzerland, Germany, Denmark, Spain, Finland, Iceland, Norway, Sweden
- Units affected: 3,465
The hazard
According to the FDA, when the 'Set day and night' feature is turned off and 'missed dose' or 'Correct high glucose' alerts are enabled, the associated alerts will not trigger during the nighttime. This could result in missed rapid-acting insulin doses without the user's knowledge, potentially leading to delayed therapy and an increased risk of hyperglycemia.
Context
GovInfoNow's records show Medtronic MiniMed has issued 13 other recalls since November 15, 2023. Recent brand recalls include a July 13, 2026 recall of the Medtronic MiniMed 670G Insulin Pump for risk of incorrect insulin delivery and a May 27, 2026 recall of the Medtronic MiniMed 780G Insulin Pump due to software errors causing insulin stoppage. Other recent recalls of similar products include the Dexcom G7 CGM App recall from April 14, 2026 (risk of missing glucose alerts) and the Dexcom ONE+ App recall from April 14, 2026 (software defect may cause glucose readings to miss hypoglycemia).